| The tumor suppressor PP2A Aβ regulates the RalA GTPase AA Sablina, W Chen, JD Arroyo, L Corral, M Hector, SE Bulmer, ... Cell 129 (5), 969-982, 2007 | 220 | 2007 |
| Identification of PP2A complexes and pathways involved in cell transformation AA Sablina, M Hector, N Colpaert, WC Hahn Cancer research 70 (24), 10474-10484, 2010 | 178 | 2010 |
| PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A–mediated inactivation in human malignant glioma P Puustinen, MR Junttila, S Vanhatupa, AA Sablina, ME Hector, ... Cancer research 69 (7), 2870-2877, 2009 | 94 | 2009 |
| Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment BA Hanks, A Holtzhausen, KS Evans, R Jamieson, P Gimpel, ... The Journal of clinical investigation 123 (9), 3925-3940, 2020 | 73 | 2020 |
| Endoglin interacts with VEGFR2 to promote angiogenesis H Tian, JJ Huang, C Golzio, X Gao, M Hector-Greene, N Katsanis, ... The FASEB Journal 32 (6), 2934-2949, 2018 | 32 | 2018 |
| TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling K Tazat, M Hector-Greene, GC Blobe, YI Henis Molecular biology of the cell 26 (19), 3535-3545, 2015 | 25 | 2015 |
| Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin L Pomeraniec, M Hector-Greene, M Ehrlich, GC Blobe, YI Henis Molecular biology of the cell 26 (17), 3117-3127, 2015 | 25 | 2015 |
| ALK1 Regulates the Internalization of Endoglin and the type III TGF-β Receptor K Tazat, L Pomeraniec-Abudy, M Hector-Greene, SS Szilágyi, S Sharma, ... Molecular Biology of the Cell, mbc. E20-03-0199, 2021 | | 2021 |
| Role of type III Transforming Growth Factor-ss receptor in regulating ALK1 signaling and endothelial biology M Hector-Greene, K Tazat, Y Henis, G Blobe ANGIOGENESIS 21 (1), 153-153, 2018 | | 2018 |
| The Role of Type III Transforming Growth Factor-β Receptor in Regulating ALK1 ME Hector-Greene Duke University, 2017 | | 2017 |
| DALANTERCEPT ALK-1 ligand trap Prop INN; USAN Angiogenesis inhibitor Treatment of solid tumors ME Hector-Greene, GC Blobe DRUGS OF THE FUTURE 40 (10), 633-637, 2015 | | 2015 |
| The role of type III TGF-beta receptor in tumor angiogenesis ME Hector-Greene, GC Blobe ANGIOGENESIS 17 (4), 963-963, 2014 | | 2014 |
| Dalantercept. ALK-1 ligand trap, Angiogenesis inhibitor, treatment of solid tumors ME Hector-Greene, GC Blobe | | |
